Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of REGN2810 Prior to Surgery in Patients With Stage II-IV Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT03565783 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03565783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03565783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of REGN2810 Prior to Surgery in Patients With Stage II-IV Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 3, 2018
Completion date
December 31, 2027
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent cutaneous squamous cell carcinoma of the head and neck, resectable cutaneous squamous cell carcinoma of the head and neck, stage ii cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iii cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8